isabelobrien, Author at European Medical Journal - Page 41 of 68

Sandoz’s Claire D’Abreu-Hayling on leading with love

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Spoonful of technology: May-June 2024

Explore the top tech stories that have shaped pharma in recent months as we explore implants to AI models, with a particular focus on antimicrobial resistance.

Spotlight: June 2024

Discover June’s top pharma news in our monthly round-up. From the latest market predictions to new vaccine development initiatives, there’s plenty to discover.

GLP-1 treatments may lower cancer risk in type 2 diabetes patients

A new study finds that patients with type 2 diabetes taking GLP-1 treatments have a reduced chance of developing obesity-related cancers.

How creativity and innovation are revolutionising medical education

Isabel is joined by Tim Uden, Creative Director, EMJ to discuss the new frontier of medical education tools and skills – interactive content.

Pride 2024: How can pharma leaders make a difference?

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

Pride Special: J&J's Edmond Chan on the value in being your authentic self

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

Phone in someone's hand with medical imagery on it

From basic to bold: Introducing interactive medical education

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.

New MS blood test to launch in Europe

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.

VML Health's Nichole Davies on the good, the bad and the ugly in women’s health

VML’s Chief Strategy Officer, Nichole Davies, talks about the pharma industry’s role in improving the quality of women’s health worldwide, including why investors need to wake up to women’s health issues.